SystemOne Launches Aspect Reporter App for Real-Time Diagnostic Results Reporting and Link to Treatment

SystemOne has launched Aspect Reporter, an Android app designed to report diagnostic lab results back to clinicians and confirm patient links to treatment.  This improves upon earlier electronic notification methods to send test results using SMS or email. The Aspect Reporter app offers bank-level security and privacy of lab results while making them all available in the clinician’s hand. Additionally, the app allows for customized workflows so health-care workers can report on follow-up, acknowledge receipt, confirm patient treatment, and more.

SystemOne Announces GxAlert and Aspect Now Support HCV and Upgraded Connection to OpenLDR

SystemOne’s commitment to linking diagnosis to treatment expands to address additional diseases and co-infections

Springfield, MA and Johannesburg, South Africa – April 29, 2019 - SystemOne, which provides the digital backbone for infectious disease diagnostics, announced today that the platforms  Aspect® and GxAlert® now transmit Hepatitis C Virus (HCV) data. Aspect and GxAlert have processed and transmitted thousands of Xpert® HCV Viral Load results in several resource-limited geographies. The platforms can also process HCV results from other devices and assays.

With HCV now curable, moving HCV diagnostic data in near real-time is critical to closing gaps between diagnosis and treatment, identifying disease hot-spots and raising cure rates, in addition to increasing efficiencies and reducing the extraordinary costs associated with infectious disease diagnostics and treatment.

An estimated 71 million people are infected with chronic HCV, and the disease is responsible for an estimated 399,000 deaths per year and 1.75 million new infections annually, according to the World Health Organization. Unlike some other infectious diseases, for example HIV and TB, the number of deaths due to viral hepatitis is increasing.

Image at right: BruceBlaus - Own work, CC BY-SA 4.0,

“Appropriate medicine can cure over 95% of persons infected with Hepatitis C,” said Chris Macek, CEO, SystemOne. “But robust data solutions are needed to inform the best use of clinical, logistical, global health and pharmaceutical resources. In addition strong data solutions will reduce loss to follow-up, increase treatment adherence and allow health ministries to understand treatment and program efficacy.”

Link to OpenLDR

SystemOne also announces an upgraded link to the Open Laboratory Data Repository (OpenLDR). The OpenLDR provides a single storage location for country-wide electronic data regarding laboratory requests and results. This allows laboratory managers to easily view relevant data for the entire country, different geographic levels or detailed data down to the lab and section.

“While our platforms were always able to link to OpenLDR, we’ve made substantial changes to integrate with Mozambique’s installation in particular,” said Stefan Baumgartner, Chief Product Engineer, SystemOne. “This upgraded link can now be used in any country to securely transmit results on a schedule to OpenLDR.”

SystemOne provides a variety of reports to countries to help them understand HCV diagnostics and results in near real-time.

About SystemOne:

Founded in Massachusetts in 2012, SystemOne produces the digital backbone of diagnostics in high disease-burden countries. SystemOne offices are located in Springfield, MA and Johannesburg, South Africa. The company’s new data platform, Aspect®, is designed from the ground up to work with any disease and any device. To contact SystemOne, email:

To contact SystemOne, email:
Stay Updated on Twitter

The SystemOne Diagnostic-to-Treatment Grant

Building A Better Link From Diagnosis to Treatment

Working in partnership with a high-burden TB country to close the lab-clinic divide and confirm treatment for all positive TB cases

March 24, 2019 — In honor of World TB day, SystemOne is proud to announce a grant opportunity of in-kind services to help the Recipient connect positive TB diagnoses to treatment. The in-kind services will focus on connecting several diagnostic devices to Aspect, the multi-disease, multi-device digital data platform, and then connecting that data to a TB case management system. SystemOne will connect a GeneXpert point of care (POC) device and central laboratory diagnostics, such as MGIT and LPA, at 1 (one) central or national-level laboratory. This connectivity with multiple instruments, and use of Aspect to link positive cases to treatment, is designed to dramatically reduce loss to follow-up, account for every positive diagnosis, and enable rapid electronic results reporting via app, email or SMS.

Also included in the grant is a data deep-dive to immediately gain insight into how patients proceed through the cascade of diagnostics and then onto treatment. The deep dive will also analyze impact measurements on turnaround time, time to treatment initiation, and the gap between diagnosis and treatment -- and how the intervention has helped to narrow that gap.

The in-kind grant’s estimated value is $70,000 USD.


A person experiencing signs and symptoms of TB faces many challenges to timely diagnosis and appropriate treatment. Many of these bottlenecks can be characterized as delays.

  • Delays between ordering a diagnostic test and receiving the results;

  • Delays in initiating treatment due to the challenges of interpreting complex results and the unavailability of appropriate drugs for treatment; and

  • Delays in proactive longitudinal monitoring of patients to prevent drug resistance and negative patient outcomes.

These delays prolong illness, fuel the outbreak of drug resistant TB (DR TB), and constrain efforts to improve patient outcomes. They make it more difficult to identify where to put resources, to notify patients and clinicians, to confirm positive diagnoses are on treatment, and to ensure appropriate treatment. Reducing these delays requires a stronger link between laboratory and clinic. New diagnostics and drugs are critical, but if they do not connect into a patient-centered model of care—the right diagnostic or drug, for the right patient, at the right time—they will have limited impact.

This grant for connecting multiple devices, combined with the resulting information flow and interpretation, addresses these delays by connecting diagnostics, harnessing their data, and moving that data in real time to actors in the health system.  Additionally, we seek to reduce time to identify and notify patients and clinicians and reduce the pretreatment Loss to Follow-up (LTFU) by confirming that all positive diagnoses are linked to appropriate treatment.

Successful Applicant will be Awarded:

  • Connection of 1 GeneXpert POC TB diagnostic instrument and up to two central laboratory DR TB diagnostic tests (ie MGIT, LPA) to Aspect. The central laboratory tests/devices will be limited to one central or national level laboratory.

  • Deployment of a mobile application to capture smear microscopy results and move them to Aspect.

  • Connection between Aspect and the currently used DR TB case management system.

  • Site visits by SystemOne staff (to be conducted within first 90 days of the grant).

  • Capacity building during site visits.

  • Data, SMS, and other running costs and remote support for one year.

  • The successful awardee will be invited to nominate 1 or 2 individuals to co-author a paper on the results of this initiative with SystemOne.

Eligibility for Award

  • Ministries of Health must submit an application by April 30, 2019 (see below for application instructions).

  • The successful awardee will need to provide a Ministry of Health-appointed point of contact to manage the project and provide all local logistical support and local travel costs for the SystemOne engineers. That person will remain the point of contact during the following 9 additional months of connectivity. Meals, lodging, incidentals and international travel costs for SystemOne engineers will be covered by SystemOne.

  • Must sign a Data Use Agreement to ensure compliance with international data usage regulations. The Data Use Agreement will be sent to applicant upon receipt of completed application.

Grant Priorities

We are looking for country applicants that can:

  1. Submit a complete application.

  2. Provide strong governmental leadership and management of laboratory diagnostics.

  3. Collaborate on final data analysis report.

  4. Nominate a responsible point of contact for the Project for one full year.

  5. Demonstrate potential collaboration between HIV and TB programs.

How to Apply

To apply, complete the application below by April 30, 2019 by copying the questions and pasting them into a text editor of your choice. Save the Application as a PDF and submit to  You may also submit any questions by emailing

Other Conditions

Nothing contained in this call for proposal creates any express or implied obligation on the part of SystemOne, including, without limitation, obligation to fund any proposal, person or entity. SystemOne will make all award decisions in response to this call for proposals at its sole discretion and any award will be contingent upon an applicant entering into a written memorandum of understanding on terms acceptable to SystemOne.

Application Form

Please copy and paste the following text into a text editor of your choice and submit the application as a PDF file to

1. General Information

1.1 Name of Country

1.2 Name and information for National TB Program Director:



Contact information:

1.3 Name, title, email, and phone number of person submitting application:





1.4 Do you have GeneXperts already connected to GxAlert (Y/N)?

1.5 Please list the types of drug sensitivity tests and devices used in 1 central/national lab:

1.6 Does your country already have a dedicated GxAlert server? (Y/N) (If No, then Aspect and/or GxAlert will be provisioned at no additional cost on SystemOne’s secure cloud platform).

2. Descriptions of Existing Connections

2.1 What is the average number of tests per day performed on the devices listed on #4 (below) at 1 central or national level laboratory?

2.2 Are the instruments at the central/national level lab connected to a laboratory information system (LIS)? If so, please name and describe the system. (200 words max.)

2.3 What electronic case management system is used to initiate and track DR TB patients on treatment (i.e. OpenMRS, eTB manager, etc)?

3. Existing Processes and Support

3.1 Describe briefly what happens after a result is generated from a diagnostic instrument? For example, does the result have to be manually approved by a clinician or lab manager before it is shown to the referring facility/patient? (400 words max.)

3.2 Describe briefly your laboratory workflow. How are results currently transferred from the instrument to both laboratory information systems and case management systems? (400 words max.)

4. Hardware and Connectivity

4.1 Are the instruments listed in the application already connected to a computer?

4.2 Does the central or national lab already have a reliable internet connection that can be utilised to move data for this project? Is this an Ethernet or WiFi connection (please specify)?

4.3 Is there a reliable wifi or 3G signal inside the lab?

4.4 Which mobile networks providers are known to work inside the lab?

4.5 Briefly describe any networks that are set up in the lab. For example, is there  a router that instruments and/or computers connect to? Do those instruments/computers connect via Wifi or Ethernet? (200 words max.)

4.6 Is there a reliable source of electricity at the lab? Are there any backup sources of electricity and are they reliable?

Optional: Is there anything else you wish us to know about your landscape, and why your country would be a strong recipient and partner for the SystemOne Diagnostic-to-Treatment Grant? (200 words max)


SystemOne, CDC and ASLM Electronic Proficiency Testing Platform (ePT) Now Used in over 900 Laboratories & Testing Sites in 24 Countries

New applications and connectivity reduces process from 4-6 week to near realtime

Springfield, MA and Johannesburg, South Africa – January 10, 2019 -  SystemOne announces that its enhanced Electronic Proficiency Testing Platform (ePT), built in collaboration with the Center for Disease Control and Prevention (CDC - Atlanta, USA) and the African Society for Laboratory Medicine (ASLM, Addis Ababa, Ethiopia) to support the global Dried Tube Specimen (DTS) program offered by the CDC is now being used in 24 countries and 900 testing sites.  

SystemOne was engaged, through the ASLM, to expand the existing ePT platform which provided an online mechanism for the submission of HIV results. The expansion adds the ability to test TB samples, as well as automated analysis and reporting of the CDC DTS samples. The current evaluation process for the DTS program took around 4-6 weeks to complete, via a manual process.

Currently, the CDC provides DTS TB samples to laboratories around the world for proficiency testing on the GeneXpert. SystemOne’s ePT platform automates both the analysis and reporting process. In addition to the software platform and connectivity, SystemOne has developed a mobile application to allow participants to be notified of new panels, submit their results and access results in an intuitive, user-friendly manner. The initial pilot for the extended ePT platform and the mobile application took place in Botswana, Nigeria and Namibia.

“This work was a natural fit given our experience with connectivity for disease intelligence and rapid detection and response, combined with our history of working with GeneXperts in over 40 countries,” said Chris Macek, CEO, SystemOne. “When data can move faster than disease, humanity wins. Making sure ePT data move quickly and accurately is important to ensuring quality as complex diagnostic devices get deployed worldwide.”

About SystemOne:

Founded in Massachusetts in 2012, SystemOne focuses on producing solutions for disease surveillance and response. SystemOne has offices in Springfield, MA and Johannesburg, South Africa. The company’s new disease intelligence software, Aspect®, addresses numerous infectious diseases including Zika, Ebola, HIV, Malaria, Hepatitis C and more on a host of diagnostic devices.

To contact SystemOne, email:
Stay Updated on Twitter

Vietnam and Cameroon to Roll Out New Aspect and GxAlert Implementations Connecting New Instruments for Rapid TB Detection and Response

GxAlert and Aspect Platforms Have Processed 6,000,000+ Results in 43 Countries

Springfield, MA and Johannesburg, South Africa – December 18, 2018 - SystemOne, the leader in moving diagnostic data for rapid disease detection and response, announces new GxAlert® and Aspect® implementations in Vietnam and Cameroon. This work is funded by CDC and will be implemented with help from FHI 360.

In Cameroon, SystemOne’s platform Aspect will link TB diagnostic results from the GeneXpert (Cepheid) and HIV Viral Load results from the m2000 (Abbott) to a sample transport application. The link will capture and monitor information regarding sample collection and referral in order to improve the existing sample transport network in Cameroon. In addition to communicating results in real-time over SMS, Aspect will also push results back to the mobile application so that healthcare workers can view them on the Mobile App, where notes, progress and patient outcomes can be added.

In Vietnam, SystemOne will provide the GxAlert platform to help the National TB Programme shed light on its national rollout of GeneXperts. The system will rapidly move data from GeneXperts to dashboards and mobile devices, in addition to providing user-configured instant alerts about new results, machine errors, inventory management and more. Using GxAlert represents a commitment to moving diagnostic results quickly, getting patients on to treatment faster and working towards internally-supported goals to fight TB and DR-TB. Vietnam's initial 10 facility pilot has commenced, and upon completion they will roll out the platform to 100 facilities.

A screenshot of the Aspect Action Dashboard for Laboratories

A screenshot of the Aspect Action Dashboard for Laboratories

The GxAlert and Aspect platforms have now processed over 6 million infectious disease diagnostic results in over 43 countries. The systems send over 50,000 user-configured notifications to health systems staff, clinicians and ministry officials each month.

About SystemOne:

Founded in Massachusetts in 2012, SystemOne focuses on producing solutions for disease surveillance and response. SystemOne has offices in Springfield and Boston, MA and Johannesburg, South Africa.

The Rise Fund Leads $5M Series A Investment in SystemOne, the Digital Backbone for Infectious Disease Diagnostics

Investment to Accelerate
linking every Diagnosis to Treatment starting with TB and HIV

Springfield, MA; Oct 2, 2018 -- SystemOne, the leader in global disease intelligence for rapid detection and response to infectious diseases and response, today announced a $5 million Series A investment led by The Rise Fund, a global impact investment fund managed by TPG Growth. Also participating in the round was EchoVC, B&Y Venture Capital Partners and strategic angel investors. EchoVC’s Eghosa Omoigui has joined SystemOne’s board of directors.

SystemOne’s platforms, GxAlert® and Aspect®, connect over 2000 diagnostic devices in 40+ countries, including Nigeria, Kenya, Pakistan, and Myanmar. Since its inception, SystemOne’s Aspect®  and GxAlert® platforms have automatically transmitted over 5 million diagnostic results, device performance data, and aggregate disease information to clinicians, healthcare ministries, and patients around the world.  Instant notifications and up-to-date dashboards provide over 50,000 alerts/month about test results, disease trends, device functionality, error rates and more.

“Information technology will fuel the next leap forward in stopping the most entrenched and crippling infectious diseases across the globe,” said Chris Macek, CEO of SystemOne. “Rapid and accurate movement of data will make global investments more effective, ensuring that health providers know where and when infectious diseases are happening, can get patients onto treatment and monitor outcomes.”

Before SystemOne, diagnostic results could take up to several months to reach health officials and patients. SystemOne’s technology connects any diagnostic device for any disease, moving results in real-time and providing health officials a single line of sight into the disease burden in their geographies. In diseases such as HIV and TB, where global funders spend $26 billion annually, such line of sight plays a critical role in optimizing investments and efforts for maximum benefit.

“We’re very excited to partner with SystemOne, to help advance innovative solutions that can bring us towards the global goal of ending tuberculosis and HIV,” said said Yemi Lalude, Partner at TPG Growth. “The company’s focus on reducing time to treatment and closing the  gaps between diagnosis and treatment – and treatment adherence – can help create significant social impact and drive economic progress in countries where HIV and TB are prevalent.”

The investment was sourced through TPG Growth’s strategic relationship with EchoVC Partners, the leading Africa-focused seed and early-stage venture capital fund that targets early to growth-stage deals in the technology sector. This follows earlier investments in companies such as Frontier Car Group and Gro Intelligence.

The investment in SystemOne will help the company accelerate linking positive diagnoses to treatment and eventually to outcome, playing a critical role in meeting and measuring international targets for TB and HIV.

About SystemOne
Founded in Massachusetts in 2012, SystemOne focuses on producing solutions for disease surveillance and response. SystemOne has offices in Springfield, MA and Johannesburg, South Africa. The company’s new disease intelligence software, Aspect®, addresses numerous infectious diseases including Zika, Ebola, HIV, Malaria, Hepatitis C and more on a host of diagnostic devices. To contact SystemOne, email:

About The Rise Fund 
The Rise Fund is the world's largest global fund committed to achieving measurable, positive social and environmental outcomes alongside competitive financial returns —what we call "complete returns." The Rise Fund is managed by TPG Growth, the global growth equity and middle market buyout platform of alternative asset firm TPG. The Rise Fund is led by a group of influential thought leaders with a deep personal and professional commitment to driving social and environmental progress. The board includes: Bill McGlashan, TPG Growth Founder and Managing partner; Bono, Jeff Skoll, Mo Ibrahim, Laurene Powell Jobs, Anand Mahindra and Pierre Omidyar. The Rise Fund's objectives align with the U.N.'s Sustainable Development Goals. The Rise Fund invests in education, energy, food and agriculture, financial services, growth infrastructure, healthcare, and technology, media, and telecommunications companies that deliver complete returns. For more information, visit

 About TPG Growth 
TPG Growth is the middle market and growth equity investment platform of TPG, the global private investment firm. With more than $13 billion of assets under management, TPG Growth targets investments in a broad range of industries and geographies. TPG Growth has the deep sector knowledge, operational resources, and global experience to drive value creation, and help companies reach their full potential. The firm is backed by the resources of TPG, which has more than $73 billion of assets under management. For more information, visit

Media Contacts
Nicolas Boillot
888.845.2610 x4

The Rise Fund/TPG
Frank Thomas
212 601 4711

EchoVC Partners

SystemOne Launches RDT Digital Integration for Aspect Platform

First Commercial, Scalable Solution Works With Any RDT

Springfield, MA and Johannesburg, South Africa – August 14, 2018 - SystemOne, the leader in global disease intelligence for rapid detection and response, has announced the integration of off-the-shelf rapid diagnostic tests (RDTs) into the Aspect® platform. Although millions of RDTs are used worldwide for the detection of HIV, Malaria, and Influenza, there are few tools available to collect, aggregate, and validate RDT results in the field.

Because of recent pressure to move RDTs into self-testing by people at home, the global health community has sought a way to collect data, both to connect individual patients for follow-up testing and counseling, and to aggregate the data to study patterns of disease. Although academic groups have experimented with methods for reading RDT results and collecting patient data, none have found widespread use.

Working with the HSTAR Programme at University of the Witwatersrand Reproductive Health and HIV Institute (Wits RHI) and supported by funding from the Bill & Melinda Gates Foundation (BMGF), SystemOne developed its approach to be flexible, scalable, and sustainable.

By integrating RDT data into the Aspect platform, the data can be accessed within minutes by the ministry of health, research team, and healthcare providers anywhere in the world. Because Aspect already integrates HIV viral load data, the solution now makes it possible to link screening tests to confirmatory tests and follow-up testing during treatment.

For the first roll-out of the functionality, SystemOne created a mobile-phone application that collects demographic data about the patient, offers guidance for performing a self-test using standard RDT, and allows the patient to take a picture of the completed test result.

A healthcare worker observing a patient performing HIV self-testing

A healthcare worker observing a patient performing HIV self-testing

A patient using the mobile app to guide her through HIV self-testing instructions

A patient using the mobile app to guide her through HIV self-testing instructions

The app asks for the patient’s interpretation of the test result. All of the data, including the picture, are uploaded to Aspect for review by healthcare workers.

Because Aspect is flexible enough to accept diagnostic data from any device, other app providers can produce their own apps to guide patients, collect data, and even automatically interpret results. For developers, integration with Aspect is as simple as making a single call to Aspect, securely delivering clinical and demographic data.

Sample Dashboard Combining HIV Self-testing and TB Reporting

Sample Dashboard Combining HIV Self-testing and TB Reporting

SystemOne products are used to collect, analyze, and deliver diagnostic data from any diagnostic device for diseases such as TB, HIV, Hepatitis, Ebola, and Zika. “We are especially excited to offer integration with RDTs,” says Aaron Oppenheimer, SystemOne VP of Product Design. “They are widespread and inexpensive, but the simplicity can come with a cost, since there has been no scalable way to gather the data. With this extension of the Aspect platform, healthcare programs can finally see what’s happening in the field, in real time.”

SystemOne Launches Action Dashboard for Laboratory and Treatment Management, Designed in Partnership with FIND

Provides Actionable Insights and Checklist-style Controls for Global Health Labs

Springfield, MA and Johannesburg, South Africa – July 30, 2018 - SystemOne, the leader in global disease intelligence for rapid detection and response, has launched a new approach for helping manage laboratories in global health settings. The “Action Dashboard” brings together a laboratory’s testing data and operational information in one place, giving laboratory managers at the local and regional levels unprecedented insights into laboratory operations, combined with user-friendly alerts about operational issues, such as devices in need of service, low stock levels, or communication issues.

Designed in partnership with the Foundation for Innovative New Diagnostics (FIND), the first Action Dashboard deployment is in Myanmar, which has been using GxAlert, SystemOne’s flagship platform for diagnostics connectivity, since 2014. The Action Dashboard represents a new level of features built on SystemOne’s next-generation platform, Aspect, with flexible, secure data management and advanced analyses in a simple, easy-to-read and easy-to-use form.

Image: The TB dashboard keeps a program updated on testing statistics, progress against targets, and issues that need to be addressed in labs - all in real time.

Image: The TB dashboard keeps a program updated on testing statistics, progress against targets, and issues that need to be addressed in labs - all in real time.

“The Action Dashboard gives labs a straightforward list of issues and actions needed, from device maintenance to data collection, and lets regional officers see what’s happening in every laboratory. It supports configurable testing targets to allow a program to plan and track its coverage for different patient populations,” said Aaron Oppenheimer, VP of Product Design, SystemOne. “Working with FIND staff, and informed by members of the Clinton Health Access Initiative as well as the Myanmar National Tuberculosis Program helped us create the ideal tool for their environment.”

“FIND is committed to optimizing the use of diagnostic data to improve patient outcomes," said Catharina Boehme, CEO, FIND. "In Myanmar, we were able to combine the expertise of SystemOne with our knowledge of the issues faced by labs every day, to develop the Action Dashboard. The Action Dashboard improves decision making by providing both clinical and operational data to give a picture of how a disease management program is working, in real time.

SystemOne products are used to collect, analyze, and deliver diagnostic data from any diagnostic device for diseases such as tuberculosis, HIV, hepatitis, Ebola, and Zika. “Our focus is on flexibility,” said Oppenheimer. “There is no one-size-fits-all solution, so we have built our platform to be easily configurable to fit the needs of Ministries and implementing organizations working in any disease, in any country. We are already working to extend the Action Dashboard.”

First Tuberculosis-Focused Data Fellowship Program Helps TB Staff from Five Countries


SystemOne, Management Sciences for Health and the Tableau Foundation Help Build Data Analytics Capacity in Tuberculosis Program Staff

July 25, 2018 – SystemOne LLC, (Springfield, MA), Management Sciences for Health (MSH) (Medford, MA) and the Tableau Foundation (Seattle, WA) recently concluded the first Data Fellowship Program for TB staff from the National TB programs and Ministries of Health. Eight participants from five participating countries attended the week-long training session in Johannesburg, using their own country’s GxAlert diagnostic data to uncover ways to improve healthcare delivery and patient impact.

“The TB Data Fellowship training is a breakthrough initiative to show the impact of data for developing effective and efficient control programs to end TB,” said Sarder Tanzir Hossain, Senior Technical Advisor, TB laboratories in Bangladesh.

“Tableau Desktop visualization has helped me to generate graphical presentations that have meaningful programmatic ‘stories’ to help drive and inform policy both at the program and ministry level,” said Lawrence Kachule, National GeneXpert Coordinator, NTP, MoH, Malawi.


The Data Fellowship Program continues a year beyond this intensive first week, and will cover further training on how to analyze, visualize and understand data collected through GxAlert. The additional mentorship will be conducted remotely and will focus on continuing skills development and sharing of best practices.


“Even though this was only the start of the program, by the end of the week, participants were able to begin exploring their own country data and developing visuals to improve the understanding and reporting for their TB program” said Natasha Gous, Medical Science Liaison and Facilitator of the TB Data Fellowship Program.

The 2018 TB Data Fellows!

The 2018 TB Data Fellows!

About SystemOne
Founded in Massachusetts in 2012, SystemOne focuses on producing solutions for disease surveillance and response. SystemOne has offices in Springfield, MA and Johannesburg, South Africa. The company’s new disease intelligence software, Aspect®, addresses numerous infectious diseases including Zika, Ebola, HIV, Malaria, Hepatitis C and more on a host of diagnostic devices.

To contact SystemOne, email:

SystemOne Launches Aspect Disease Intelligence Platform

Dramatic step forward in disease detection and response to link to treatment, curb outbreaks, and end epidemics

Springfield, MA and Johannesburg, South Africa – June 27, 2018 -  SystemOne today announced the launch of Aspect, a new disease intelligence platform based on the company’s work in over 40 countries. Aspect offers countries a proven means to understand disease burdens, accelerate response, and manage diagnostic equipment and supplies.  

Aspect is a completely new iteration of a product that began as GxAlert, the first platform to connect GeneXperts in 40+ countries, managing nearly 5 million TB, Ebola, and HIV diagnostic results. Aspect extends these capabilities to connect to any device and handle any diagnostic data in any country.

Aspect offers advanced features for clinical and operational control, and provides an extremely flexible platform, with easily customizable reports and SMS, email and dashboard communications. Some of Aspect’s features include:

  • Delivering diagnostic results to clinicians, supervisors, officials and even patients
  • Collecting and protecting patient data
  • Linking diagnosis to treatment
  • Stock-out prevention and supply management
  • Supply use-rate analysis and forecasting
  • Device utilization and maintenance analysis
  • Fully customizable communication and reporting features
  • Advanced user permissions to control data access
  • Easy integration with laboratory information systems or EMRs
  • World-class data protection and security
Image: Aspect provides flexible operational and clinical dashboards, with data from lab devices, POC, and RDTs in one place to enable better, faster decisions.

Image: Aspect provides flexible operational and clinical dashboards, with data from lab devices, POC, and RDTs in one place to enable better, faster decisions.

“Medical diagnostics are the key to identifying and responding to disease as quickly as possible,” said Chris Macek, CEO of SystemOne. “Unfortunately, the power of diagnostics cannot be unlocked if data isn’t delivered and interpreted rapidly. If data can move faster than disease, humanity will win the fight against rapidly-spreading infectious diseases.”

“Today, around the world, our customers are deploying platforms ranging from electronic medical records (EMRs) to laboratory information systems,” said Aaron Oppenheimer, Product Manager for Aspect. “Our mission is to create the missing piece that ensures the rapid movement of actionable data through health systems, acting in concert with whatever other data systems a customer has. For regions or health systems that have no data infrastructure, Aspect can manage it all. Aspect ensures the right information gets to the right person at the right time in the cycle of care.”